Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with cardiovascular diseaseau-amcau-racgpau-racp

A 59-year-old man with long-standing type 2 diabetes and obesity has HbA1c 8.5% despite maximal metformin and lifestyle change. He has established atherosclerotic cardiovascular disease but normal renal function. According to Australian diabetes guidance, which additional agent is preferred to improve glycaemic control and cardiovascular outcomes?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.